HealthNews

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis – PR Newswire

August 16, 2025
Less than a minute

  1. Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire
  2. Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com
  3. Novo Nordisk’s Wegovy Gets US Approval for Liver Disease  Bloomberg.com
  4. Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance
  5. Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters

Source link

Related posts:

  1. FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors – PR Newswire
  2. FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
  3. FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
  4. New antibody delivery system boosts Alzheimer’s treatment in mice
See also  100 new Christmas films to watch this season
Tags
August 16, 2025
Less than a minute
Photo of Digit

Digit

Digit is a versatile content creator with expertise in Health, Technology, Movies, and News. With over 7 years of experience, he delivers well-researched, engaging, and insightful articles that inform and entertain readers. Passionate about keeping his audience updated with accurate and relevant information, Digit combines factual reporting with actionable insights. Follow his latest updates and analyses on DigitPatrox.
Back to top button
close